GlassScriptPhysician profile
Lisa J Stearns
NPI 1902876717
$57,259.03
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $47K · 2020: $10K.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $38,039.35 | 2019 | |
| Boston Scientific Corporation | $3,866.42 | 2019-2020 | |
| West Therapeutics Development, LLC | $2,582.39 | 2019 | |
| Vertiflex, INC. | $1,635.60 | 2019 | |
| Nevro Corp. | $439.71 | 2019-2020 | |
| Flowonix Medical Incorporated | $357.85 | 2019 | |
| Stimwave Technologies Incorporated | $180.43 | 2019 | |
| Abbott Laboratories | $94.24 | 2020 | |
| Collegium Pharmaceutical, INC. | $66.07 | 2019-2020 | |
| Amgen INC. | $61.80 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.16 | 2019-2020 | |
| Tersera Therapeutics LLC | $58.85 | 2019 | |
| Allergan, INC. | $53.20 | 2019 | |
| Scilex Pharmaceuticals INC. | $39.07 | 2019 | |
| Zyla Life Sciences, INC. | $38.58 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $36.71 | 2019 | |
| Sentynl Therapeutics, INC. | $36.46 | 2019 | |
| Biodelivery Sciences International, INC. | $33.19 | 2019-2020 | |
| Tactile Systems Technology INC | $23.08 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $22.67 | 2019 | |
| Ethicon US, LLC | $14.44 | 2019 | |
| Spr Therapeutics, INC | $13.62 | 2019 | |
| Medtronic, INC. | $12.26 | 2019 |
4 companies reported research payments only; those appear in the research section below.
Research and ownership
$537.50 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Stearns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.